Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.
Attaya SuvannasankhaNizar BahlisSuzanne TrudelKatja WeiselChristian KoeneckeAlbert OriolPeter M VoorheesAranzazu A AlonsoNatalie S CallanderMaría-Victoria MateosNishitha ReddyShawn HakimJohn LaMacchiaNashita PatelDanaé WilliamsRoxanne C JewellXiangdong ZhouIra GuptaJoanna OpalinskaAjay K NookaPublished in: Cancer (2024)
gov as NCT03848845.